From the 14F-1
I believe the new majority owners have the connections and experience to add value to HDYN. Could it be that Mr. Armanious is interested in merging some assets into our corporate structure to diversify HDYN's asset base and attract additional investors to increase the asset value of HDYN? We'll see, these proposed board members are at least qualified and have contacts in the west African petroleum business.
Still cautiously optimistic,
Red
Proposed Directors
Markos Armanious. Mr. Armanious is a professional Geologist and businessman with over 30 years’ experience in the exploration and development of conventional and unconventional oil and gas fields both in North America and worldwide. His expertise is applied to the assessment of producing acquisition opportunities, and to the maximization of their value.
Currently, Mr. Armanious is the 50% owner of Tycanol Holdings LLC, a private Company as well as Chairman of CLNG (Hong Kong) Ltd.
Mr. Armanious spent several years as the Director and General Manager of GNPC-AGM Operating Company Limited, Ghana. A privately held company in a joint venture company between Minexco Petroleum and the Ghana National Petroleum Corporation. Prior to that assignment, Mr. Armanious was the Chief Operating Officer of Minexco Petroleum Ltd., Gibraltar, an Exploration company with assets in Ghana and Sierra Leone
Mr. Armanious holds a B.Sc. Geology from the University of Calgary and a B.Sc. (Adv.) Physiology from the University of Saskatchewan.
Yiling Yang. Mr Yang is currently the Vice President of the China Office of Panamerican Union Oil and Gas in Beijing, China. Previously, Mr. Yang held executive positions at the Panamerican Union Oil and Gas Group and Beijing Korking Hi-Tec Company PLC, in Beijing.
Mr. Yang received a degree from Beijing International Studies University.
Dr. David Ho. Dr. Ho is a medical doctor and HIV/AIDS researcher and is currently the scientific director and chief executive officer of the Aaron Diamond AIDS Research Center and is the Irene Diamond Professor at Rockefeller in New York City. Dr. Ho is also an administrator to the Bill and Melinda Gates Foundation.
Dr. Ho received his bachelor of science in physics with highest honors from the California Institute of Technology and MD from the Harvard-MIT Division of Health Sciences and Technology.
Dr. Ho is a leading figure in the fight against HIV and is internationally recognized as one of the leaders in this field. Dr. Ho published over 400 papers enabling the scientific community to understand the mechanism of HIV replication and his team is working on developing vaccines for AIDS. He heads a consortium of organizations in China and the U.S. to address the crisis of HIV/AIDS in China.
Manfred Shiu. Manfred Shiu holds a Bachelor Degree in Accountancy and he is a fellow member of the Association of Chartered Certified Accountants. Mr. Shiu has more than 20 years’ intensive exposure in corporate finance, mergers & acquisitions, investments, Initial Public Offerings (“IPO”) as well as fund raising in various ventures and projects related to Chinese state owned enterprises (“SOE”) and public listed companies in Hong Kong, the Peoples Republic of China, Malaysia, Singapore, and Indonesia.
Mr. Shiu is the founder of Euto Capital Partners Limited (“Euto”), a boutique advisory firm focus in providing corporate finance, merger and acquisition and pre-IPO advisory for the China, Hong Kong and South East Asia market. Prior to establishing Euto, Mr. Shiu was the responsible officer of Upbest Securities Company Limited and Upbest Assets Management Limited, both companies are wholly owned subsidiaries of Upbest Group Limited, a Company listed on the Hong Kong Stock Exchange.
